Prograf (Tacrolimus)
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Prograf (Tacrolimus), covering 2007-08-20 to 2017-06-28. Get the full timeline:
Most recent: Clinical Trial Update: Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant [Phase 2]